Contagious Dog Cancer Sequenced

A dog tumor that became a free-living parasite picked up myriad mutations, but has since stabilized.

By | January 23, 2014

An Alaskan malamuteWIKIPEDIA, SCMWThousands of years ago, a tumor cell from the genitals of a dog evolved into an immortal, free-living parasite. Rather than dying with its host, it gained the ability to spread from one dog to another through sexual contact. This contagious cancer, now known as canine transmissible venereal tumor (CTVT), has spread to dogs all over the world, and it is the oldest known cell line in existence.

Now, a team of scientists led by Elizabeth Murchison at the University of Cambridge has sequenced the genomes of two CTVTs. Their results, published today (January 23) in Science, show that this extraordinary cancer first arose around 11,000 years ago. From its genes, the team could even tell that it arose in a medium-to-large dog that looked like a husky or Alaskan malamute, and either had a solid black coat or a grizzled one with light and dark bands.

“If we found the bones of that dog somewhere, it would have been considered ancient DNA,” said Murchison. “But its cells are still alive and we’re sequencing its DNA today. It’s mind-boggling.”

Earlier studies predicted that all current CTVTs shared a common ancestor between 250 and 2,500 years ago, but the tumor itself is between 7,800 and 78,000 years old. Murchison’s team narrowed that range down to between 10,200 and 12,900 years by considering the total number of mutations in CTVT in the context of the mutation rate of a human cancer: medulloblastoma.

“These predictions of age are difficult, as they are only as accurate as the estimated mutation rate,” said Hannah Siddle from the University of Southampton in an e-mail. “But this work confirms that CTVT is most likely many thousands of years old and this is in line with previous estimates.”

The genomes revealed mutation on a massive scale. Since its days as a dog cell, CTVT has picked up around 1.9 million mutations; by contrast, a typical human cancer has only acquired from 1,000 to 5,000. The team also found around 350 instances of jumping genes landing in new places—2,200 cases where large chunks of the genome had been rearranged, and around 650 genes that had been lost entirely. “It makes you wonder how it’s survived all these years,” said Murchison.

Around half the tumor’s genes carry at least one non-synonymous mutation—one that changes an amino acid in the encoded protein. Surprisingly, around 40 percent of these are of a type that is caused by ultraviolet light exposure. CTVT normally grows inside a dog’s genital orifices, but when it gets big enough to breach the surface (and spread to another dog), it could easily see enough sunlight to pick up UV-induced mutations. 

But the team also found that CTVT, despite its history of untrammelled mutation, is now relatively stable. The researchers specifically sequenced two tumors that would be as different as possible: one derived from an Aboriginal camp dog in Maningrida, Australia, the other from an American cocker spaniel in Franca, Brazil.

These two tumors represent lineages of CTVT that separated from one another around 500 years ago, but they look virtually identical. Around 95 percent of their mutations are shared. On top of that, each tumor largely consisted of identical clonal cells. In human cancers, different parts of the same tumor can harbor very different sets of mutations. But the team couldn’t find any hint of these “sub-clones” within the CTVTs.

“There’s not a lot of new evolution going on,” said Murchison. “This tell us that cancers do have this potential to go on living for thousands of years and, given the opportunity, they can become a more stable entity than cancers we usually see in humans.”

 “CTVT may represent an evolutionary ‘endpoint’ for a tumor,” said Siddle. “Perhaps the tumor has become perfectly adapted to its niche and is not under further positive selection.”

The CTVT genomes also show that the cancer originated in an isolated dog population that was probably highly inbred. It stayed there for most of its history, before hopping a ride around the world during the age of exploration and global seafaring.

A second transmissible cancer has also evolved in Tasmanian devils, and causes a fatal condition called devil facial tumor disease (DFTD). DFTD has only acquired around 20,000 mutations, but Katherine Belov from the University of Sydney sees many parallels between the two tumors. “Both diseases appear to have emerged in populations with low genetic diversity,” she told The Scientist in an e-mail. “Then, over time, they both evolved immune evasion strategies, and have become remarkably stable cell lines.”

“I think it is really important that we continue to study these contagious cancers,” she added. “They have evolved at least twice. What allows these cancers to emerge, and to become successful and immortal? If we can answer these questions, we will gain insights into human cancers too.”

E. P. Murchison et al., “Transmissable dog cancer genome reveals the origin and history of an ancient cell lineage,” Science, 343: 437-40, 2014.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: mitodoc


Posts: 5

January 24, 2014

This is fascinating and I really appreciate this succinct and informative summation of the very long article in Science.  Thank you for keeping us informed.

Avatar of: Curculio


Posts: 61

January 24, 2014

There is actually a third contagious cancer found in the Syrian Hamster:

If one wants to change the concept a bit to include cancers that have escaped their initial host, we need to include HeLa, as well.  

Avatar of: JonRichfield


Posts: 135

January 25, 2014

I am interested in various aspects of the story but will watch reports dealing with four in particular:

1: How did such an effectively parthenogenic population undergo such extensive mutation and yet achieve such uniformity without stabilising feedback? Could it be that the feedback is in the dogs rather than the cell population, that dogs infected with widely "non-standard" lines simply died without passing on their tumours?

2: There is a remarkably wide tendency in many diseases (eg syphilis and Yersinia in Europe), for the pathogen to become less virulent with time within the available host population. It doesn't seem to happen all cases, such as rabies for example, to which humanity seems to have developed no herd tolerance, possibly because humans do not seem to be a medium in which the disease propagates well. This seems to be true of rabies in most mammals, with rare exceptions such as the Yellow mongoose in South Africa. No doubt this tendency to reduced virulence is a matter of simple reciprocal selection resulting in or amounting to mutual adaptation of host to parasite, such as in myxomatosis, but there are many cases in which it is hard to imagine how both populations could have been mutually exposed to selection sufficiently intense to achieve such marked effects within just a few generations. Which aspects of such mutual accommodation might be effective in this case of canine tumour tissues?

3: Are there cases (and if not, why not?) where trans-species tumour populations occur? It seems to me conceptually possible in cases of close cohabitation, parasitism, or predation or combat for example. How about bears, cats and the like?

4: The nature of (Darwinian selective) evolution seems to me to require careful analysis in making sense of a case such as this, with unclear feedback and little role for genetic recombination. I don't have the concept worked out to my personal satisfaction as yet.

Avatar of: JonRichfield


Posts: 135

Replied to a comment from Curculio made on January 24, 2014

January 25, 2014

@Curculio, thanks for pointing out the hamster line and the WP URL, and I accept that HeLa is a valid topic to mention in this connection, but don't you think that in context HeLa is a bit at a tangent from populations that are viably self-transmissable?

Just thinking about it. If you convince me and no one beats me to the punch I might add suitable remarks and references to the WP article.

Avatar of: Katia


Posts: 4

January 29, 2014

It's interesting that transmissible cancers seem to affect species/ populations that have undergone a genetic bottleneck, as in CTVT is said to had arisen in an inbred dog population. May that be a case of host's "selfish" DNA evolving into an immortal parasite to be a "rat" that "abandons a sinking ship" (i.e. a probably dying out population)? Interestingly, CTVT can spread to other, though closely related, canine species e.g. foxes, coyotes. Considering what JonRichfield has said earlier, I don't think we'll see cancer spreading from e.g. a mouse to a cat yet, at least for a while, because cancers probably evolve to deal with specific genetic mechanisms of immunity (i.e. their host's) and in this case a mouse cancer probably couldn't cope with cat's immunity - ?

Avatar of: alexpeterson


Posts: 1

January 30, 2014

How they date genes age?

Avatar of: Saber8m


Posts: 1

February 4, 2014

Where is the EVIDENCE

Avatar of: JonRichfield


Posts: 135

Replied to a comment from Katia made on January 29, 2014

February 22, 2014


Sorry, wasn't sulking, but this medium doesn't seem to alert one to comments, so I never saw your reply till I happened to pass by.

I largely agree with you about SAY cat-mouse transmission ( though I could easily imagine some types of tissue implantation succeeding if the invader is for some reason not penetrable by the host's immune cells or is covered in non-immunogenic secretions through which nutrients can diffuse). However, it seems a little easier or at any rate more plausible that a tumour from say a dog, might infect a jackal (a wolf might more or less amount to the same species) or possibly Lycaon pictus, or bears, or even cats.)

It is not always easy to know where to draw the line, nor to guess what might become of an at first barely-viable population that eventually becomes more successfully adapted.

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials